TickerFacts.

Idexx Laboratories Inc (IDXX): Gross Profit

Annual figures by period end, from SEC filings.

$2.66B
Year ended 2025-12-31
$2.84B
Trailing 12 months to 2026-06-30
+9.9%
3-year compound annual growth
+11.1%
5-year compound annual growth
+11.6%
10-year compound annual growth
2008-12-31: $529.77M2009-12-31: $526.28M2010-12-31: $578.62M2011-12-31: $646.51M2012-12-31: $699.15M2013-12-31: $756.12M2014-12-31: $816.12M2015-12-31: $890.27M2016-12-31: $975.44M2017-12-31: $1.10B2018-12-31: $1.24B2019-12-31: $1.37B2020-12-31: $1.57B2021-12-31: $1.89B2022-12-31: $2.00B2023-12-31: $2.19B2024-12-31: $2.38B2025-12-31: $2.66B$2.66B
2008-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$2.66B+11.8%2026-02-20, From 2025-01-01
2024-12-31$2.38B+8.6%2026-02-20, From 2024-01-01
2023-12-31$2.19B+9.3%2026-02-20, From 2023-01-01
2022-12-31$2.00B+6.1%2025-02-21, From 2022-01-01
2021-12-31$1.89B+20.3%2024-02-22, From 2021-01-01
2020-12-31$1.57B+15.0%2023-02-16, From 2020-01-01
2019-12-31$1.37B+10.0%2022-02-16, From 2019-01-01
2018-12-31$1.24B+13.1%2021-02-12, From 2018-01-01
2017-12-31$1.10B+12.5%2020-02-14, From 2017-01-01
2016-12-31$975.44M+9.6%2019-02-15, From 2016-01-01
2015-12-31$890.27M+9.1%2018-02-16, From 2015-01-01
2014-12-31$816.12M+7.9%2017-02-17, From 2014-01-01
2013-12-31$756.12M+8.1%2016-02-17, From 2013-01-01
2012-12-31$699.15M+8.1%2015-02-17, From 2012-01-01
2011-12-31$646.51M+11.7%2014-02-18, From 2011-01-01
2010-12-31$578.62M+9.9%2013-02-19, From 2010-01-01
2009-12-31$526.28M-0.7%2012-02-17, From 2009-01-01
2008-12-31$529.77Mn/a2011-02-22, From 2008-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Idexx Laboratories Inc (IDXX)2025-12-31$2.66B+11.8%
Lantheus Holdings, Inc. (LNTH)2025-12-31$941.95M-4.7%
Neogen Corp (NEOG)2026-05-31$408.50M-3.1%
Myriad Genetics Inc (MYGN)2025-12-31$576.60M-1.5%
Alpha Teknova, Inc. (TKNO)2025-12-31$13.44M+85.9%
Immucell Corp (ICCC)2025-12-31$11.45M+44.1%
Aspira Women's Health Inc. (AWHL)2025-12-31$5.92M+8.0%
Anbio Biotechnology (NNNN)2025-12-31$7.54M+28.2%
Biomerica Inc (BMRA)2026-05-31$362.0K-27.3%

Compare IDXX, LNTH, NEOG, MYGN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗